A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

被引：131

作者：

Alsoussi, Wafaa B. ^{[1
]}

Turner, Jackson S. ^{[1
]}

Case, James B. ^{[2
]}

Zhao, Haiyan ^{[1
]}

Schmitz, Aaron J. ^{[1
]}

Zhou, Julian Q. ^{[3
]}

Chen, Rita E. ^{[2
]}

Lei, Tingting ^{[1
]}

Rizk, Amena A. ^{[1
]}

McIntire, Katherine M. ^{[1
]}

Winkler, Emma S. ^{[1
,2
]}

Fox, Julie M. ^{[2
]}

Kafai, Natasha M. ^{[1
,2
]}

Thackray, Larissa B. ^{[2
]}

Hassan, Ahmed O. ^{[2
]}

Amanat, Fatima ^{[4
,5
]}

Krammer, Florian ^{[4
]}

Watson, Corey T. ^{[6
]}

Kleinstein, Steven H. ^{[3
,7
,8
]}

Fremont, Daved H. ^{[1
,9
,10
]}

Diamond, Michael S. ^{[1
,2
,9
,11
,12
]}

Ellebedy, Ali H. ^{[1
,9
,11
,12
]}

机构：

[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA

[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA

[3] Yale Univ, Yale Sch Med, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06511 USA

[4] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10024 USA

[5] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10024 USA

[6] Univ Louisville, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA

[7] Yale Sch Med, Dept Pathol, New Haven, CT 06511 USA

[8] Yale Sch Med, Dept Immunobiol, New Haven, CT 06511 USA

[9] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA

[10] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA

[11] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO 63110 USA

[12] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63110 USA

来源：

JOURNAL OF IMMUNOLOGY | 2020年 / 205卷 / 04期

基金：

美国国家卫生研究院;

关键词：

MONOCLONAL-ANTIBODIES; SPIKE PROTEIN; CORONAVIRUS; IMMUNOGLOBULIN; EXPRESSION; TOOLKIT; CLONING; COV;

D O I：

10.4049/jimmunol.2000583

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for millions of infections and hundreds of thousands of deaths globally. There are no widely available licensed therapeutics against SARS-CoV-2, highlighting an urgent need for effective interventions. The virus enters host cells through binding of a receptor-binding domain within its trimeric spike glycoprotein to human angiotensin-converting enzyme 2. In this article, we describe the generation and characterization of a panel of murine mAbs directed against the receptor-binding domain. One mAb, 2B04, neutralized wild-type SARS-CoV-2 in vitro with remarkable potency (half-maximal inhibitory concentration of <2 ng/ml). In a murine model of SARS-CoV-2 infection, 2B04 protected challenged animals from weight loss, reduced lung viral load, and blocked systemic dissemination. Thus, 2B04 is a promising candidate for an effective antiviral that can be used to prevent SARS-CoV-2 infection.

引用

页码：915 / 922

页数：8

共 50 条

[41] Neutralizing antibody responses against SARS-CoV-2 in vaccinated people with multiple sclerosis
Gyang, Tirisham, V
Evans, John P.
Miller, Joseph S.
Alcorn, Kariss
Peng, Juan
Bell, Erica H.
Zeng, Cong
Gumina, Richard
Liu, Shan-Lu
Segal, Benjamin M.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2022, 8 (01)
[42] Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection
Linderman, Susanne L.
Lai, Lilin
Gamarra, Estefany L. Bocangel
Lau, Max S. Y.
Edupuganti, Srilatha
Surie, Diya
Tenforde, Mark W.
Chappell, James D.
Mohr, Nicholas M.
Gibbs, Kevin W.
Steingrub, Jay S.
Exline, Matthew C.
Shapiro, Nathan I.
Frosch, Anne E.
Qadir, Nida
Davis-Gardner, Meredith E.
McElrath, M. Juliana
Lauring, Adam S.
Suthar, Mehul S.
Patel, Manish M.
Self, Wesley H.
Ahmed, Rafi
JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (23):
[43] Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection
Monroe, Jonathon M.
Haralambieva, Iana H.
Warner, Nathaniel D.
Grill, Diane E.
Quach, Huy Quang
Kennedy, Richard B.
HELIYON, 2022, 8 (11)
[44] Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
Zhang, Haiying
Jia, Yuyuan
Ji, Ying
Cong, Xu
Liu, Yan
Yang, Ruifeng
Kong, Xiangsha
Shi, Yijun
Zhu, Ling
Wang, Zhenyu
Wang, Wei
Fei, Ran
Liu, Feng
Lu, Fengmin
Chen, Hongsong
Rao, Huiying
FRONTIERS IN MICROBIOLOGY, 2022, 13
[45] Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques
Edwards, Christopher T.
Karunakaran, Kirti A.
Garcia, Elijah
Beutler, Nathan
Gagne, Matthew
Golden, Nadia
Aoued, Hadj
Pellegrini, Kathryn L.
Burnett, Matthew R.
Honeycutt, Christopher Cole
Lapp, Stacey A.
Ton, Thang
Lin, Mark C.
Metz, Amanda
Bombin, Andrei
Goff, Kelly
Scheuermann, Sarah E.
Wilkes, Amelia
Wood, Jennifer S.
Ehnert, Stephanie
Weissman, Stacey
Curran, Elizabeth H.
Roy, Melissa
Dessasau, Evan
Paiardini, Mirko
Upadhyay, Amit A.
Moore, Ian N.
Maness, Nicholas J.
Douek, Daniel C.
Piantadosi, Anne
Andrabi, Raiees
Rogers, Thomas R.
Burton, Dennis R.
Bosinger, Steven E.
PLOS PATHOGENS, 2025, 21 (01)
[46] Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys
Jilei Jia
Zhaojuan Yin
Xiao Zhang
Huimin Li
Dan Meng
Qianqian Liu
Hongfang Wang
Meng Han
Shixiang Suo
Yan Liu
Ping Hu
Chunyun Sun
Jing Li
Liangzhi Xie
Pharmaceutical Research, 2022, 39 : 2191 - 2201
[47] Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses
Einhauser, Sebastian
Asam, Claudia
Weps, Manuela
Senninger, Antonia
Peterhoff, David
Bauernfeind, Stilla
Asbach, Benedikt
Carnell, George William
Heeney, Jonathan Luke
Wytopil, Monika
Fuchs, Andre
Messmann, Helmut
Prelog, Martina
Liese, Johannes
Jeske, Samuel D.
Protzer, Ulrike
Hoelscher, Michael
Geldmacher, Christof
Ueberla, Klaus
Steininger, Philipp
Wagner, Ralf
EBIOMEDICINE, 2024, 110
[48] Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys
Jia, Jilei
Yin, Zhaojuan
Zhangl, Xiao
Li, Huimin
Meng, Dan
Liu, Qianqian
Wang, Hongfang
Han, Meng
Suo, Shixiang
Liu, Yan
Hu, Ping
Sun, Chunyun
Li, Jing
Xie, Liangzhi
PHARMACEUTICAL RESEARCH, 2022, 39 (09) : 2191 - 2201
[49] A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice
Cao, Kangli
Wang, Xiang
Peng, Haoran
Ding, Longfei
Wang, Xiangwei
Hu, Yangyang
Dong, Lanlan
Yang, Tianhan
Hong, Xiujing
Xing, Man
Li, Duoduo
Zhu, Cuisong
He, Xiangchuan
Zhao, Chen
Zhao, Ping
Zhou, Dongming
Zhang, Xiaoyan
Xu, Jianqing
JOURNAL OF VIROLOGY, 2022, 96 (04)
[50] An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Hassan, Ahmed O.
Shrihari, Swathi
Gorman, Matthew J.
Ying, Baoling
Yaun, Dansu
Raju, Saravanan
Chen, Rita E.
Dmitriev, Igor P.
Kashentseva, Elena
Adams, Lucas J.
Mann, Colin
Davis-Gardner, Meredith E.
Suthar, Mehul S.
Shi, Pei-Yong
Saphire, Erica Ollmann
Fremont, Daved H.
Curiel, David T.
Alter, Galit
Diamond, Michael S.
CELL REPORTS, 2021, 36 (04):

← 1 2 3 4 5 →